Phase I and pharmacokinetic study of halofuginone, an oral quinazolinone derivative in patients with advanced solid tumours.

M. D. de Jonge,H. Dumez,J. Verweij,S. Yarkoni,D. Snyder,D. Lacombe,S. Marréaud,T. Yamaguchi,C. Punt,A. V. van Oosterom
DOI: https://doi.org/10.1016/J.EJCA.2005.12.027
IF: 10.002
2006-08-01
European Journal of Cancer
Abstract:
What problem does this paper attempt to address?